{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:25:52Z","timestamp":1788272752339,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI14C1324"],"award-info":[{"award-number":["HI14C1324"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education","award":["2017R1D1A1B03029050"],"award-info":[{"award-number":["2017R1D1A1B03029050"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Interleukin (IL)-16 is a T cell chemoattractant produced by peripheral mononuclear cells. We investigated whether IL-16 plays a pro- or an anti-inflammatory role in antineutrophil cytoplasmic antibody-associated vasculitis (AAV). Furthermore, we investigated whether the level of IL-16 could predict the activity and extent of organ damage in AAV based on AAV-specific indices.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Seventy-eight patients with AAV from a prospective observational cohort were included in this analysis. Blood sampling and clinical assessments, including the Birmingham Vasculitis Activity Score (BVAS), Five-Factor Score (FFS), Short Form 36-item Health Survey (SF-36), and Vasculitis Damage Index (VDI), were performed, and laboratory data were collected. Serum IL-16 was measured from stored sera.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The median age was 62.0\u2009years, and 27 patients were male. The median serum IL-16 concentration was 84.1\u2009pg\/dL, and the median BVAS, FFS, VDI, and SF-36 scores were 7.0, 1.0, 3.0, and 48.0, respectively. Among the AAV-related indices, the serum IL-16 concentration was correlated with VDI (<jats:italic>R<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20090.306,<jats:italic>P<\/jats:italic>\u2009=\u20090.006), but not with BVAS (<jats:italic>R<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20090.024,<jats:italic>P<\/jats:italic>\u2009=\u20090.834), FFS (<jats:italic>R<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u2009\u2212\u20090.069,<jats:italic>P<\/jats:italic>\u2009=\u20090.550), or SF-36 (<jats:italic>R<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u2009\u2212\u20090.015,<jats:italic>P<\/jats:italic>\u2009=\u20090.898). The serum IL-16 concentration also did not correlate with either the erythrocyte sedimentation rate or the C-reactive protein concentration. Per our analysis based on organ involvement, only patients with ear, nose, and throat manifestations had higher serum IL-16 concentrations relative to those with other conditions (<jats:italic>P<\/jats:italic>\u2009=\u20090.030).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This was the first study to elucidate the clinical implication of serum IL-16 in patients with AAV. We found that the serum IL-16 level may reflect the cross-sectional VDI scores among AAV-specific indices. Future studies with larger numbers of patients and serial measurements could provide more reliable data on the clinical implications of serum IL-16 in AAV.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13075-020-02172-5","type":"journal-article","created":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T12:03:58Z","timestamp":1586261038000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Serum interleukin-16 significantly correlates with the Vasculitis Damage Index in antineutrophil cytoplasmic antibody-associated vasculitis"],"prefix":"10.1186","volume":"22","author":[{"given":"Taejun","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Yoon","family":"Pyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Soo","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason Jungsik","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Beom","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8038-3341","authenticated-orcid":false,"given":"Sang-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,7]]},"reference":[{"key":"2172_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1\u201311.","journal-title":"Arthritis Rheum"},{"key":"2172_CR2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1136\/ard.2006.054593","volume":"66","author":"R Watts","year":"2007","unstructured":"Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis. 2007;66:222\u20137.","journal-title":"Ann Rheum Dis"},{"key":"2172_CR3","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1136\/ard.2008.101279","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S, et al. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis. 2009;68:1827\u201332.","journal-title":"Ann Rheum Dis"},{"key":"2172_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","volume":"90","author":"L Guillevin","year":"2011","unstructured":"Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Le Toumelin P, et al. The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore). 2011;90:19\u201327.","journal-title":"Medicine (Baltimore)"},{"key":"2172_CR5","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s11926-012-0291-1","volume":"14","author":"K Bhamra","year":"2012","unstructured":"Bhamra K, Luqmani R. Damage assessment in ANCA-associated vasculitis. Curr Rheumatol Rep. 2012;14:494\u2013500.","journal-title":"Curr Rheumatol Rep"},{"key":"2172_CR6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1620\/tjem.203.189","volume":"203","author":"CW Han","year":"2004","unstructured":"Han CW, Lee EJ, Iwaya T, Kataoka H, Kohzuki M. Development of the Korean version of Short-Form 36-Item Health Survey: health related QOL of healthy elderly people and elderly patients in Korea. Tohoku J Exp Med. 2004;203:189\u201394.","journal-title":"Tohoku J Exp Med"},{"key":"2172_CR7","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.4049\/jimmunol.128.6.2569","volume":"128","author":"W Cruikshank","year":"1982","unstructured":"Cruikshank W, Center DM. Modulation of lymphocyte migration by human lymphokines. II. Purification of a lymphotactic factor (LCF). J Immunol. 1982;128:2569\u201374.","journal-title":"J Immunol"},{"key":"2172_CR8","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/jlb.67.6.757","volume":"67","author":"WW Cruikshank","year":"2000","unstructured":"Cruikshank WW, Kornfeld H, Center DM. Interleukin-16. J Leukoc Biol. 2000;67:757\u201366.","journal-title":"J Leukoc Biol"},{"key":"2172_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/08977190410001704679","volume":"22","author":"KC Wilson","year":"2004","unstructured":"Wilson KC, Center DM, Cruikshank WW. The effect of interleukin-16 and its precursor on T lymphocyte activation and growth. Growth Factors. 2004;22:97\u2013104.","journal-title":"Growth Factors"},{"key":"2172_CR10","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1093\/rheumatology\/37.12.1334","volume":"37","author":"S Lee","year":"1998","unstructured":"Lee S, Kaneko H, Sekigawa I, Tokano Y, Takasaki Y, Hashimoto H. Circulating interleukin-16 in systemic lupus erythematosus. Br J Rheumatol. 1998;37:1334\u20137.","journal-title":"Br J Rheumatol"},{"key":"2172_CR11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3858\/emm.2008.40.2.237","volume":"40","author":"ML Cho","year":"2008","unstructured":"Cho ML, Jung YO, Kim KW, Park MK, Oh HJ, Ju JH, et al. IL-17 induces the production of IL-16 in rheumatoid arthritis. Exp Mol Med. 2008;40:237\u201345.","journal-title":"Exp Mol Med"},{"key":"2172_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cyto.2015.12.002","volume":"78","author":"A Murota","year":"2016","unstructured":"Murota A, Suzuki K, Kassai Y, Miyazaki T, Morita R, Kondo Y, et al. Serum proteomic analysis identifies interleukin 16 as a biomarker for clinical response during early treatment of rheumatoid arthritis. Cytokine. 2016;78:87\u201393.","journal-title":"Cytokine."},{"key":"2172_CR13","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.4049\/jimmunol.162.7.4293","volume":"162","author":"PA Klimiuk","year":"1999","unstructured":"Klimiuk PA, Goronzy JJ, Weyand CM. IL-16 as an anti-inflammatory cytokine in rheumatoid synovitis. J Immunol. 1999;162:4293\u20139.","journal-title":"J Immunol"},{"key":"2172_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-pathol-011811-132453","volume":"8","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Hu P, Xiao H. Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. Annu Rev Pathol. 2013;8:139\u201360.","journal-title":"Annu Rev Pathol"},{"key":"2172_CR15","unstructured":"Kawabata K, Makino T, Makino K, Kajihara I, Fukushima S, Ihn H. IL-16 expression is increased in the skin and sera of patients with systemic sclerosis. Rheumatology (Oxford). 2020;59:519\u2013523."},{"key":"2172_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cyto.2008.11.007","volume":"46","author":"WG Glass","year":"2009","unstructured":"Glass WG, Argentieri RL, Bracht M, Farrell FX, Das AM, Del Vecchio AM, et al. Generation of bleomycin-induced lung fibrosis is independent of IL-16. Cytokine. 2009;46:17\u201323.","journal-title":"Cytokine."},{"key":"2172_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.388","volume":"7","author":"S Roth","year":"2016","unstructured":"Roth S, Solbach W, Laskay T. IL-16 and MIF: messengers beyond neutrophil cell death. Cell Death Dis. 2016;7:e2049.","journal-title":"Cell Death Dis"},{"key":"2172_CR18","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3109\/08830189809043007","volume":"16","author":"WW Cruikshank","year":"1998","unstructured":"Cruikshank WW, Kornfeld H, Center DM. Signaling and functional properties of interleukin-16. Int Rev Immunol. 1998;16:523\u201340.","journal-title":"Int Rev Immunol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02172-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-020-02172-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02172-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T16:54:22Z","timestamp":1696006462000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-020-02172-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,7]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2172"],"URL":"https:\/\/doi.org\/10.1186\/s13075-020-02172-5","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,7]]},"assertion":[{"value":"7 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board of Severance Hospital (4-2016-0901), and written informed consent was obtained from the patients at the time of blood sampling.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}